Alzheimer’s disease

Alzheimer’s disease is a progressive neurodegenerative disorder and the most common cause of dementia. It is characterized by the accumulation of amyloid-beta plaques and tau tangles in the brain, leading to cognitive decline, memory loss, and behavioral changes.

Recent data suggests a shift in the trajectory of dementia incidence. Contrary to historical projections of rising case numbers due to aging populations, evidence indicates a potential decline in new dementia cases in certain demographics.

Pathophysiology

The disease involves the death of brain cells and the breakdown of neural connections. Key pathological features include:

  • Amyloid Plaques: Clumps of beta-amyloid protein fragments that build up between nerve cells.
  • Neurofibrillary Tangles: Twisted fibers of tau protein that build up inside cells.
  • Neuroinflammation: Chronic inflammation plays a significant role in the progression of neuronal damage.

Treatment and Management

While there is currently no cure, management strategies focus on slowing progression and improving quality of life.

  • Pharmacological: Cholinesterase inhibitors (e.g., donepezil) and NMDA receptor antagonists (e.g., memantine) are standard treatments for symptom management.
  • Emerging Therapies: Recent progress in Alzheimer’s Treatment Progress includes monoclonal antibodies targeting amyloid-beta, which have shown modest but significant benefits in slowing cognitive decline in early-stage patients.
  • Non-Pharmacological: Cognitive stimulation, physical exercise, and social engagement are critical components of care.

Prevention and Risk Reduction

Lifestyle modifications are strongly associated with reduced risk:

  • Cardiovascular Health: Managing blood pressure, cholesterol, and blood sugar levels.
  • Diet: Mediterranean or MIND diets rich in antioxidants and healthy fats.
  • Cognitive Engagement: Lifelong learning and mental stimulation help build cognitive reserve.

References